176 related articles for article (PubMed ID: 2418960)
1. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.
Shipley GD; Pittelkow MR; Wille JJ; Scott RE; Moses HL
Cancer Res; 1986 Apr; 46(4 Pt 2):2068-71. PubMed ID: 2418960
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
3. Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta.
Rollins BJ; O'Connell TM; Bennett G; Burton LE; Stiles CD; Rheinwald JG
J Cell Physiol; 1989 Jun; 139(3):455-62. PubMed ID: 2472411
[TBL] [Abstract][Full Text] [Related]
4. Two subtypes of reversible cell cycle restriction points exist in cultured normal human keratinocyte progenitor cells.
Wilke MS; Hsu BM; Scott RE
Lab Invest; 1988 Jun; 58(6):660-6. PubMed ID: 2454348
[TBL] [Abstract][Full Text] [Related]
5. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
[TBL] [Abstract][Full Text] [Related]
6. Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.
Reiss M; Sartorelli AC
Cancer Res; 1987 Dec; 47(24 Pt 1):6705-9. PubMed ID: 2445478
[TBL] [Abstract][Full Text] [Related]
7. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
8. Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements.
Pittelkow MR; Shipley GD
J Cell Physiol; 1989 Sep; 140(3):565-76. PubMed ID: 2550477
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation.
Woodworth CD; Chung J; McMullin E; Plowman GD; Simpson S; Iglesias M
Cell Growth Differ; 1996 Jun; 7(6):811-20. PubMed ID: 8780894
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
11. [Transforming growth factor beta and fibroblast growth factor have opposite effects on the proliferation of endothelial cells].
Fràter-Schröder M; Müller G; Birchmeier W; Böhlen P
Schweiz Med Wochenschr; 1986 Aug; 116(34):1160-2. PubMed ID: 3464090
[TBL] [Abstract][Full Text] [Related]
12. Secretion of a TGF-beta-like growth inhibitor by normal rat mammary epithelial cells in vitro.
Ethier SP; Van de Velde RM
J Cell Physiol; 1990 Jan; 142(1):15-20. PubMed ID: 2298817
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of BALB/c mouse keratinocytes by TGF-beta 1 and CeReS-18 appears to act through distinct mechanisms.
Betz NA; Fattaey HK; Johnson TC
Exp Cell Res; 1996 Aug; 227(1):47-54. PubMed ID: 8806450
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
[TBL] [Abstract][Full Text] [Related]
15. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
16. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies.
Wille JJ; Pittelkow MR; Shipley GD; Scott RE
J Cell Physiol; 1984 Oct; 121(1):31-44. PubMed ID: 6207187
[TBL] [Abstract][Full Text] [Related]
17. Growth modulation of mouse keratinocytes by transforming growth factors.
Coffey RJ; Sipes NJ; Bascom CC; Graves-Deal R; Pennington CY; Weissman BE; Moses HL
Cancer Res; 1988 Mar; 48(6):1596-602. PubMed ID: 2449957
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta.
Zendegui JG; Inman WH; Carpenter G
J Cell Physiol; 1988 Aug; 136(2):257-65. PubMed ID: 2457593
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture.
McMahon JB; Richards WL; del Campo AA; Song MK; Thorgeirsson SS
Cancer Res; 1986 Sep; 46(9):4665-71. PubMed ID: 3089593
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
Carr BI; Hayashi I; Branum EL; Moses HL
Cancer Res; 1986 May; 46(5):2330-4. PubMed ID: 3008986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
